Daiwa Securities Group
BDTX icon

Daiwa Securities Group’s Black Diamond Therapeutics BDTX Stock Holding History

Daiwa Securities Group’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-106
Closed – – 1323
2022
Q3 		$0 Hold
106
– – ﹤0.01% 1340
2022
Q2 		$0 Hold
106
– – ﹤0.01% 1362
2022
Q1 		$0 Hold
106
– – ﹤0.01% 1378
2021
Q4 		$1K Buy
106
+38
+56% +$265 ﹤0.01% 1327
2021
Q3 		$1K Hold
68
– – ﹤0.01% 1262
2021
Q2 		$1K Hold
68
– – ﹤0.01% 1182
2021
Q1 		$2K Hold
68
– – ﹤0.01% 1137
2020
Q4 		$2K Buy
+68
New +$2.23K ﹤0.01% 1114

Other funds holding BDTX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Daiwa Securities Group's BDTX Position: Q4 2022 in Review

Daiwa Securities Group sold out of Black Diamond Therapeutics (BDTX) in Q4 2022, closing a stake of 106 shares.

Daiwa Securities Group first reported a position in BDTX in Q4 2020 and held it in 8 quarters. The position peaked at $2K in Q1 2021. 59 funds tracked by Wall St. Rank hold BDTX as of Q4 2022.

  • Daiwa Securities Group reported no remaining Black Diamond Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 106 Black Diamond Therapeutics shares in Q4 2022.
  • Daiwa Securities Group first reported a position in Black Diamond Therapeutics in Q4 2020 and held it in 8 quarters.
  • Daiwa Securities Group's Black Diamond Therapeutics position peaked at $2K in Q1 2021.
  • 59 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.